This site is intended for Healthcare Professionals only

overactive bladder

white tablet summary.jpg

MHRA rejects POM to P switch for oxybutynin medicine

Evidence shows medical supervision is still required to ensure safe use of Aquiette, says MHRA

15 May 2023

overactive bladder, summary.jpg

Mixed reaction to proposed oxybutynin POM to P switch

Some pharmacists have criticised a proposal to reclassify the drug for overactive bladder in women.

25 Apr 2022

Change privacy settings